2-phenylbenzothiazole has been researched along with memantine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shoji, M | 1 |
| Barnham, KJ; Donnelly, PS; Hill, AF; Johanssen, T; Liu, XM; Petrou, S; Suphantarida, N | 1 |
1 review(s) available for 2-phenylbenzothiazole and memantine
| Article | Year |
|---|---|
[Drug therapy for Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Clioquinol; Drug Design; Excitatory Amino Acid Antagonists; Flurbiprofen; Indoles; Memantine; Meta-Analysis as Topic; Randomized Controlled Trials as Topic | 2010 |
1 other study(ies) available for 2-phenylbenzothiazole and memantine
| Article | Year |
|---|---|
PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning.
Topics: Animals; Animals, Newborn; Calcineurin; Cerebral Cortex; Clioquinol; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycogen Synthase Kinase 3; Memantine; Metals; Mice; Mice, Inbred C57BL; Neurons; Time Factors | 2015 |